Exact Mass: 309.0684

Exact Mass Matches: 309.0684

Found 64 metabolites which its exact mass value is equals to given mass value 309.0684, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

N-(6-Oxo-6H-dibenzo[b,d]pyran-3-yl)maleamic acid

C17H11NO5 (309.0637)

Glymidine

N-[5-(2-methoxyethoxy)-2-pyrimidinyl]benzenesulphonamide

C13H15N3O4S (309.0783)

A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BC - Sulfonamides (heterocyclic) C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent

Glycodiazine

N-[5-(2-Methoxyethoxy)pyrimidin-2-yl]benzenesulphonamide

C13H15N3O4S (309.0783)

Glycodiazine is used with diet to lower blood glucose by increasing the secretion of insulin from pancreas and increasing the sensitivity of peripheral tissues to insulin. The mechanism of action of glycodiazine in lowering blood glucose appears to be dependent on stimulating the release of insulin from functioning pancreatic beta cells, and increasing sensitivity of peripheral tissues to insulin. Glycodiazine likely binds to ATP-sensitive potassium channel receptors on the pancreatic cell surface, reducing potassium conductance and causing depolarization of the membrane. Membrane depolarization stimulates calcium ion influx through voltage-sensitive calcium channels. This increase in intracellular calcium ion concentration induces the secretion of insulin. It is used for the concomitant use with insulin for the treatment of noninsulin-dependent (type 2) diabetes mellitus. A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BC - Sulfonamides (heterocyclic) C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent

Glucose aspartate

8-amino-3,4,4a,10a-tetrahydroxy-2-(hydroxymethyl)-tetrahydro-2H-pyrano[2,3-b][1,4]dioxocine-6,9-dione

C10H15NO10 (309.0696)

N(4)-Acetylsulfisoxazole

N-{4-[(3,4-dimethyl-1,2-oxazol-5-yl)sulphamoyl]phenyl}ethanimidic acid

C13H15N3O4S (309.0783)

D000890 - Anti-Infective Agents > D013424 - Sulfanilamides

Romazarit

2-{[2-(4-chlorophenyl)-4-methyl-1,3-oxazol-5-yl]methoxy}-2-methylpropanoic acid

C15H16ClNO4 (309.0768)

C29629 - Combination Medication > C29634 - Antirheumatic Preparation

CRL-40,940

C15H13F2NO2S (309.0635)

Nor-S-(-)-SCH-23388 hydrochloride

C16H17Cl2NO (309.0687)

2-AMINO-4-(3,4-DIFLUOROPHENYL)-5H-INDENO[1,2-D]PYRIMIDIN-5-ONE

C17H9F2N3O (309.0714)

3-(3H-imidazol-4-yl)-2-[(4-methylphenyl)sulfonylamino]propanoic acid

C13H15N3O4S (309.0783)

Acetic acid, [4-[(2,4-dioxo-5-thiazolidinyl)methyl]phenoxy]-, ethyl ester

C14H15NO5S (309.0671)

Sulfisoxazole Acetyl

sulfisoxazole acetyl (200 mg)

C13H15N3O4S (309.0783)

C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent D000890 - Anti-Infective Agents > D013424 - Sulfanilamides

1H-Benzimidazole,5-[5-[(3-pyridinylmethyl)thio]-1,3,4-oxadiazol-2-yl]-(9CI)

C15H11N5OS (309.0684)

1H-Benzimidazole,5-[5-[(4-pyridinylmethyl)thio]-1,3,4-oxadiazol-2-yl]-(9CI)

C15H11N5OS (309.0684)

ethyl (E)-3-(2-chloro-6-fluorophenyl)-2-(1,2,4-triazol-1-ylmethyl)prop-2-enoate

C14H13ClFN3O2 (309.068)

(Z)-1-phenyl-2-(bromomethyl)-N,N-diethylcyclopropanecarboxamide

C15H20BrNO (309.0728)

4-[[(4-CHLORO-2,5-DIMETHYLPHENYL)SULFONYL]METHYL]ANILINE

C15H16ClNO2S (309.059)

methyl (2S)-2-(2-chlorophenyl)-2-(2-thiophen-2-ylethylamino)acetate

C15H16ClNO2S (309.059)

N-(3,5-Dinitrobenzoyl)-DL-proline

C12H11N3O7 (309.0597)

N-(3,5-Dinitrobenzoyl)-D-proline

C12H11N3O7 (309.0597)

Irosustat

C14H15NO5S (309.0671)

C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor

N-(5-chloro-2-pyridinyl)-2-(3,5-dimethyl-4-nitro-1-pyrazolyl)acetamide

C12H12ClN5O3 (309.0629)

2-Chloro-1-[1-[2-(4-chlorophenyl)ethyl]-2,5-dimethyl-3-pyrrolyl]ethanone

C16H17Cl2NO (309.0687)

6-(2-Furanyl)-3-(2-pyridinylmethylthio)-[1,2,4]triazolo[4,3-b]pyridazine

C15H11N5OS (309.0684)

1-[[2-(1H-benzimidazol-2-ylthio)-1-oxoethyl]amino]-3-ethylthiourea

C12H15N5OS2 (309.0718)

5-Phosphoribosyl-4,5-aminoimidazole

C8H14N4O7P- (309.06)

(2R)-2-amino-3-(1H-indol-3-ylmethylcarbamothioylsulfanyl)propanoic acid

C13H15N3O2S2 (309.0606)

8-amino-3,4,4a,10a-tetrahydroxy-2-(hydroxymethyl)-3,4,7,8-tetrahydro-2H-pyrano[2,3-b][1,4]dioxocine-6,9-dione

C10H15NO10 (309.0696)

N-(4-tert-butyl-2-thiazolyl)-4-chlorobenzohydrazide

C14H16ClN3OS (309.0703)

5-(4-methylpiperazin-1-yl)sulfonyl-1H-indole-2,3-dione

C13H15N3O4S (309.0783)

6-[[(2-Methoxycarbonyl-3-thiophenyl)amino]-oxomethyl]-1-cyclohex-3-enecarboxylic acid

C14H15NO5S (309.0671)

N-[5-(3,4-dimethoxyphenyl)-1,3,4-thiadiazol-2-yl]carbamic acid ethyl ester

C13H15N3O4S (309.0783)

N-[(E)-(3-nitrophenyl)methylideneamino]-1-benzofuran-2-carboxamide

C16H11N3O4 (309.075)

N-[5-(ethoxymethyl)-1,3,4-thiadiazol-2-yl]-2-(phenylthio)acetamide

C13H15N3O2S2 (309.0606)

2-(2-methoxyethylthio)-N-(5-methyl-1,3,4-thiadiazol-2-yl)benzamide

C13H15N3O2S2 (309.0606)

Phenguignardate

C18H13O5- (309.0763)

A monocarboxylic acid anion that is the conjugate base of phenguignardic acid, obtained from the derotonation of the carboxy group. Major species at pH 7.3.

4-[(E)-[[5-(Trifluoromethyl)pyridin-2-yl]hydrazinylidene]methyl]benzoic acid

C14H10F3N3O2 (309.0725)

2-[(2,4-Dichlorobenzyl)amino]-1-phenyl-1-propanol

C16H17Cl2NO (309.0687)

aristolactam c ii; 1'-carboxylic acid,o2-de-me

C17H11NO5 (309.0637)

{"Ingredient_id": "HBIN016768","Ingredient_name": "aristolactam c ii; 1'-carboxylic acid,o2-de-me","Alias": "NA","Ingredient_formula": "C17H11NO5","Ingredient_Smile": "NA","Ingredient_weight": "309.27","OB_score": "NA","CAS_id": "106283-33-4","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "6676","PubChem_id": "NA","DrugBank_id": "NA"}